Claire Villeneuve

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Cross Sectional

End Stage Renal Disease

Ejection Fraction

Top Venues

Transplantation direct

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Claire Villeneuve, Antoine Humeau, Caroline Monchaud, Marc Labriffe, Jean-Phillipe Rerolle, Lionel Couzi, Pierre-François Westeel, Isabelle Etienne, Nassim Kamar, Mathias Büchler, Antoine Thierry, Pierre Marquet
Better Rejection-Free Survival at Three Years in Kidney Transplant Recipients With Model-Informed Precision Dosing of Mycophenolate Mofetil. Clinical pharmacology and therapeutics (2024)
Claire Villeneuve, Jean-Phillipe Rerolle, Lionel Couzi, Pierre-Francois Westeel, Isabelle Etienne, Laure Esposito, Nassim Kamar, Mathias Büchler, Antoine Thierry, Pierre Marquet, Caroline Monchaud
The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients Over the First Year Posttransplantation. Transplantation direct 10 (8) (2024)
Claire Villeneuve, Antoine Humeau, Caroline Monchaud, Marc Labriffe, Jean-Phillipe Rerolle, Lionel Couzi, Pierre-François Westeel, Isabelle Etienne, Nassim Kamar, Mathias Büchler, Antoine Thierry, Pierre Marquet
Better Rejection-Free Survival at Three Years in Kidney Transplant Recipients With Model-Informed Precision Dosing of Mycophenolate Mofetil. Clinical pharmacology and therapeutics 116 (2) (2024)
Claire Villeneuve, Jean-Phillipe Rerolle, Lionel Couzi, Pierre-Francois Westeel, Isabelle Etienne, Laure Esposito, Nassim Kamar, Mathias Büchler, Antoine Thierry, Pierre Marquet, Caroline Monchaud
The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients Over the First Year Posttransplantation. Transplantation direct 10 (8) (2024)